ELVN – Enliven Therapeutics Inc
Investors holding1
Combined shares13,601
Combined reported value$623K
ELVN chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Paul Tudor Jones narrow view | 0.00 | Reduced 66.1% | 13,601 | $623K | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 66.1% | 13,601 | 0.01 |
| Q2 2026 | Paul Tudor Jones narrow view | New | 40,118 | 0.01 |
| Q1 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.00 |
| Q4 2025 | Stanley Druckenmiller narrow view | Closed | 0 | 0.49 |
| Q4 2025 | Paul Tudor Jones narrow view | Added 82.0% | 29,673 | 0.00 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Paul Tudor Jones narrow view | New | 40,118 | 0.01 |
| Q4 2025 | Paul Tudor Jones narrow view | Added 82.0% | 29,673 | 0.00 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 66.1% | 13,601 | 0.01 |
| Q1 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.00 |
| Q4 2025 | Stanley Druckenmiller narrow view | Closed | 0 | 0.49 |
History
2 peakQ3 2026: 1 tracked investors
20242026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Paul Tudor Jones | 13.6K | 40.1K | – | 29.7K | 16.3K | – | 13.4K | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).